CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q422 Q123 Q223 Q323 Q423 Q124 Q224 Q324 Q424 Revenues: Clearing and transaction fees 981.4 1,200.2 1,118.3 1,085.5 1,184.5 1,208.9 1,249.9 1,297.1 1,232.3 Market data and information services 153.2 165.8 163.1 167.6 167.2 175.4 175.0 178.2 181.6 Other Revenue 73.2 75.6 78.8 84.7 87.6 103.6 107.6 109.1 111.4 Total revenues 1,207.8 1,441.6 1,360.2 1,337.8 1,439.3 1,487.9 1,532.5 1,584.4 1,525.3 Expenses: Compensation and benefits 193.0 204.5 205.7 205.5 212.9 206.0 204.7 218.8 220.8 Technology 50.0 51.3 53.3 55.6 58.5 59.4 64.1 66.6 65.7 Professional fees and outside services 38.5 38.3 37.8 32.2 36.1 33.1 34.7 31.0 33.9 Amortization of purchased intangibles 56.7 56.8 57.0 57.2 55.6 55.2 55.5 55.7 55.3 Depreciation and amortization 33.9 31.9 32.3 31.1 30.7 30.1 28.7 28.2 28.1 Licensing and other fee agreements 72.4 84.7 78.2 79.5 80.4 87.9 85.9 97.6 84.0 Other expense 95.0 60.4 57.3 56.5 101.9 56.6 58.3 62.3 90.4 Operating expenses 539.5 527.9 521.6 517.6 576.1 528.3 531.9 560.2 578.2 Operating Income 668.3 913.7 838.6 820.2 863.2 959.6 1,000.6 1,024.2 947.1 Operating Margin 55% 63% 62% 61% 60% 64% 65% 65% 62% Non-operating Income and Expense Investment income 1,152.2 1,357.7 1,568.2 1,272.5 1,076.9 1,071.3 1,044.5 1,026.8 936.5 Interest and other borrowing costs (39.9) (39.9) (40.2) (39.6) (39.7) (39.9) (40.1) (40.2) (40.7) Equity in net gains (losses) of unconsolidated subsidiaries 64.0 78.2 75.1 76.8 66.8 87.2 86.4 86.1 91.2 Other non-operating income (expense) (1,017.3) (1,152.8) (1,425.3) (1,155.6) (961.2) (964.8) (936.9) (920.0) (837.5) Non-operating income (expense) 159.0 243.2 177.8 154.1 142.8 153.8 153.9 152.7 149.5 Income before income taxes 827.3 1,156.9 1,016.4 974.3 1,006.0 1,113.4 1,154.5 1,176.9 1,096.6 Income taxes 189.4 273.1 238.8 224.1 191.4 258.2 271.3 264.1 222.0 Net income 637.9 883.8 777.6 750.2 814.6 855.2 883.2 912.8 874.6 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 637.9 883.8 777.6 750.2 814.6 855.2 883.2 912.8 874.6 Net Income Attributable to Common Shareholders of CME Group 629.9 872.7 767.8 740.8 804.3 844.4 872.1 901.3 863.7 Effective Tax Rate 22.8% 23.6% 23.5% 23.0% 19.0% 23.2% 23.2% 22.4% 20.2% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 1.76 2.43 2.14 2.06 2.24 2.35 2.43 2.51 2.40 Diluted EPS 1.75 2.43 2.14 2.06 2.24 2.35 2.42 2.50 2.40 Weighted average number of common stock shares: Basic Shares 358,885 358,933 358,940 359,020 359,197 359,258 359,330 359,400 359,568 Diluted Shares 359,190 359,313 359,429 359,619 359,693 359,833 359,869 359,989 360,050 Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q422 Q123 Q223 Q323 Q423 Q124 Q224 Q324 Q424 Revenues: Clearing and transaction fees 981.4 1,200.2 1,118.3 1,085.5 1,184.5 1,208.9 1,249.9 1,297.1 1,232.3 Market data and information services 153.2 165.8 163.1 167.6 167.2 175.4 175.0 178.2 181.6 Other Revenue 73.2 75.6 78.8 84.7 87.6 103.6 106.6 109.2 111.3 Total revenues 1,207.8 1,441.6 1,360.2 1,337.8 1,439.3 1,487.9 1,531.5 1,584.5 1,525.2 Expenses: Compensation and benefits 184.6 192.8 194.4 193.5 204.4 196.1 201.7 207.5 218.9 Technology 50.0 51.3 53.3 55.6 58.5 59.4 64.1 66.6 65.7 Professional fees and outside services 38.5 38.3 37.8 32.2 36.1 33.1 34.7 31.0 33.9 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 33.9 31.9 31.8 31.1 29.8 29.3 28.7 28.2 28.0 Licensing and other fee agreements 72.4 84.7 78.2 79.5 80.4 87.9 85.9 97.6 84.0 Other expense 84.5 59.7 56.2 56.5 80.3 56.5 58.6 57.9 89.7 Operating expenses 463.9 458.7 451.7 448.4 489.5 462.3 473.7 488.8 520.2 Operating Income 743.9 982.9 908.5 889.4 949.8 1,025.6 1,057.8 1,095.7 1,005.0 Operating Margin 62% 68% 67% 66% 66% 69% 69% 69% 66% Non-operating Income and Expense Investment income 1,147.1 1,277.5 1,564.0 1,276.6 1,068.5 1,061.7 1,033.0 1,022.3 943.8 Interest and other borrowing costs (39.9) (39.9) (40.2) (39.6) (39.7) (39.9) (40.1) (40.2) (40.7) Equity in net gains (losses) of unconsolidated subsidiaries 76.2 91.5 88.6 90.4 85.1 100.7 98.8 99.7 104.8 Other non-operating income (expense) (1,023.3) (1,160.6) (1,429.9) (1,157.1) (958.8) (964.8) (936.9) (920.0) (837.5) Non-operating income (expense) 160.1 168.5 182.5 170.3 155.1 157.7 154.8 161.8 170.4 Income before income taxes 904.0 1,151.4 1,091.0 1,059.7 1,104.9 1,183.3 1,212.6 1,257.5 1,175.4 Income taxes 206.0 269.1 254.6 241.7 240.2 272.2 280.4 280.5 256.5 Net income 698.0 882.3 836.4 818.0 864.7 911.1 932.2 977.0 918.9 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 698.0 882.3 836.4 818.0 864.7 911.1 932.2 977.0 918.9 Net Income Attributable to Common Shareholders of CME Group 689.1 871.1 825.9 807.8 853.8 899.7 920.4 964.7 907.4 Effective Tax Rate 22.8% 23.4% 23.3% 22.8% 21.7% 23.0% 23.1% 22.3% 21.8% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 1.92 2.43 2.30 2.25 2.38 2.50 2.56 2.68 2.52 Diluted EPS 1.92 2.42 2.30 2.25 2.37 2.50 2.56 2.68 2.52 Weighted average number of common stock shares: Basic Shares 358,885 358,933 358,940 359,020 359,197 359,258 359,330 359,400 359,568 Diluted Shares 359,190 359,313 359,429 359,619 359,693 359,833 359,869 359,989 360,050 Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 2 of 2 --